Drugs and biologics :
hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995--a consumer's perspective, June 19, 1995--FDA review process.

Description

Corporate Author

United States. Congress.

Language(s)

English

Published

Washington : U.S. G.P.O. : 1995.

Subjects

United States. > United States. / Food and Drug Administration.
Pharmacokinetics.
Biological Availability.
Drugs > Drugs / Testing > Drugs / Testing / Economic aspects > Drugs / Testing / Economic aspects / United States.
Drugs > Drugs / Testing > Drugs / Testing / Health aspects > Drugs / Testing / Health aspects / United States.
Drugs > Drugs / Bioavailability > Drugs / Bioavailability / United States.

Note

"Serial no. 104-23."
Shipping list no.: 95-0306-P.
Distributed to some depository libraries in microfiche.

Physical Description

iii, 175 p. : ill. ; 24 cm

ISBN

0160475058

Locate a Print Version

Find in a library

Viewability